While these numbers are exciting, we know how rapidly the industry is changing. We must work across life sciences organizations and with community partners to navigate the new demands.
Thanks to new funding from the American Rescue Plan through the US Economic Development Administration’s Good Jobs Challenge, we can come together to tackle these challenges head on.
*According to Pennsylvania Department of Community and Economic Development
Keystone LifeSci Collaborative Appoints Maurie Smith as Managing Director
Keystone LifeSci Collaborative announces the appointment of Maurie Smith as its first-ever Managing Director. This marks a significant moment for the Keystone LifeSci Collaborative as it fulfills its initial goal of hiring a dedicated leader to propel its life science industry-led initiatives forward. Smith brings over a decade of experience in anchor-based economic development, with a specialization in creating and managing large industry-specific collaboratives focused on policy, programmatic, and physical initiatives.
Wistar investing $24M to establish new campus & launch HIV Cure & Viral Disease…
The Wistar Institute is investing $24 million on a campus expansion project that will create an HIV Cure and Viral Disease Center. The center will be housed on a new Wistar North campus at 3675 Market St. in University City and feature more than 25,000 square feet of laboratory and office space.
New Report Documents Momentum in Greater Philadelphia’s Cell and Gene Therapy Ecosystem
Nearly 10 percent of the world’s cell and gene therapy companies are based in Greater Philadelphia, and the industry now employs more than 7,000 people in the region, a sign of the depth and breadth of this fast-growing industry, according to a study commissioned by the Chamber of Commerce for Greater Philadelphia.
Integral Molecular spinout targets $10 billion antibody reagent market
Cell Surface Bio was spun out of Integral Molecular, a 23-year-old University City biotechnology company that uses its expertise in targeted biology antibody discovery, virology, and protein engineering to help drug developers advance potential new therapies for difficult to treat diseases.
Pioneering The First Cell Therapy For Solid Tumors
Back in February, the FDA approved the first cell therapy for solid tumors — Iovance Biotherapeutics’ Amtagvi (lifileucel). Amtagvi is an autologous T-cell the ...
New collective brings Philly’s booming life sciences industry under one umbrella
As the life sciences industry in Philadelphia continues to build momentum, stakeholders now have a single hub to come together and discuss sector challenges.